King Pharmaceuticals to Sell Rochester, Michigan Manufacturing Facility to JHP Pharmaceuticals

King Pharmaceuticals and JHP Pharmaceuticals announced today the signing of an asset purchase agreement, pursuant to which JHP will acquire King's Rochester, Michigan sterile manufacturing facility, some of King's legacy products that are manufactured there, and the related contract manufacturing business. The companies also entered into a manufacturing and supply agreement pursuant to which JHP will provide certain fill and finish support with respect to King's hemostatic product, Thrombin-JMI (thrombin, topical, bovine, USP).
Business Wire via Yahoo! Finance